Previous Article | Next Article 
Journal of Virology, May 1999, p. 3718-3722, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Activation of the grp78 and
grp94 Promoters by Hepatitis C Virus E2 Envelope
Protein
Eva
Liberman,1
Yiu-Lian
Fong,2
Mark J.
Selby,2
Qui-Lim
Choo,2
Lawrence
Cousens,2
Michael
Houghton,2 and
T. S.
Benedict Yen1,3,*
Department of Pathology, University of
California,1 and Pathology Service,
Veterans Affairs Medical Center,3 San
Francisco, and Chiron Corporation,
Emeryville,2 California
Received 2 September 1998/Accepted 19 January 1999
 |
ABSTRACT |
The hepatitis C virus E1 and E2 envelope proteins are targeted to
the endoplasmic reticulum, but instead of being secreted, they are
retained in a pre-Golgi compartment, at least partly in a misfolded
state. Since secretory proteins which are retained in the endoplasmic
reticulum frequently can activate the transcription of intraluminal
chaperone proteins, we measured the effect of the E1 and E2 proteins on
the promoters of two such chaperones, GRP78 (BiP) and GRP94. We found
that E2 but not E1 protein activates these two promoters, as assayed by
a reporter gene system. Furthermore, E2 but not E1 protein induces the
synthesis of GRP78 from the endogenous cellular gene. We also found
that E2 but not E1 protein expressed in mammalian cells is bound
tightly to GRP78. This association may explain the ability of E2
protein to activate transcription, since GRP78 has been postulated to
be a sensor of stress in the endoplasmic reticulum. Since
overexpression of GRP78 has been shown to decrease the sensitivity of
cells to killing by cytotoxic T lymphocytes and to increase
tumorigenicity and resistance to antitumor drugs, this activity of E2
protein may be involved in the pathogenesis of hepatitis C
virus-induced diseases.
 |
INTRODUCTION |
Hepatitis C virus (HCV) is a member
of the Flavivididae family and causes the majority of non-A,
non-B viral hepatitis in developed nations (10). In contrast
to most RNA viruses, HCV causes chronic infection in the majority of
those infected. In addition to being at risk for chronic hepatitis and
cirrhosis, these chronically infected people also show an increased
susceptibility to hepatocellular carcinoma. The viral genome is a
single-stranded RNA approximately 9.5 kb in length (10, 23).
There is a single open reading frame just over 9 kb in length, which
codes for a polyprotein that is proteolytically processed into at least
10 polypeptides. The structural proteins, comprising the capsid (core) protein, the envelope proteins E1 and E2, and possibly p7, are present
in that order at the N-terminal end of the polyprotein (Fig.
1). These proteins are released from each
other by the signal peptidase in the endoplasmic reticulum (ER), to
which the polyprotein is targeted by a signal sequence in the core
domain (14). The final result is that both the E1 and E2
proteins end up as luminal ER proteins, with their C termini anchored
in the ER membrane.

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 1.
Map of the HCV genome, with the untranslated regions
shown as lines and the open reading frame shown as a box divided into
the final protein products. The thick lines indicate the regions
included in the various expression plasmids used in this study.
|
|
The E1 and E2 proteins can interact with each other to form
noncovalently linked dimers, and it is presumed that these dimers form
the functional subunit of the viral envelope (8, 12, 21).
However, when expressed in cultured cells, E1-E2 dimers are formed both
slowly and inefficiently (7-9). Instead, heterogeneous complexes of disulfide-linked E1 and E2 are formed. These complexes appear to be aggregates of misfolded proteins that are probably incompetent for viral morphogenesis. The reason for the formation of
these aggregates is unclear. One possibility is that they result from
overexpression in cultured cells. However, it is also possible that
this represents a mechanism for HCV to downregulate its replication rate so as to avoid immune surveillance and/or cytopathic effects. Indeed, electron microscopy of hepatocytes from HCV-infected people has
revealed dilated ER with fluffy material within the lumen, consistent
with large protein aggregates (30).
It is known that in mammalian cells the accumulation of misfolded
proteins within the ER activates an intracellular signaling pathway
known as the ER stress response. The presence of misfolded proteins is
sensed by the cell and leads to the transcriptional activation of a
subset of genes, including those encoding ER luminal chaperone
proteins, such as GRP78 (BiP) and GRP94 (15). This feedback response presumably assists the cell in folding and secreting the misfolded proteins. Since the E1 and E2 proteins can accumulate as
misfolded aggregates in the ER, we tested if expression of these
proteins would lead to increased transcription from the grp78 and grp94 promoters. Our results show that
E2 but not E1 protein activates transcription from these two promoters
and that E2 but not E1 protein is stably associated with GRP78.
 |
MATERIALS AND METHODS |
Plasmids.
The plasmids used for expressing HCV proteins
contain the cytomegalovirus immediate-early promoter and are derived
from the plasmid pCMV6 (2). The HCV-derived inserts were
amplified by PCR of cDNA clones of HCV-1 (4, 25), using
appropriate primers. The HCV966 clone expresses codons 1 through 966, the core clone expresses codons 1 through 191, the NS3 clone expresses
codons 1027 through 1711, the E1 clone expresses codons 192 through
382, and the E2 clone expresses codons 383 through 715. The last two plasmids also contain the tissue plasminogen activator signal peptide
fused to the HCV sequences at the N terminus (2), to allow
direction of the expressed proteins into the ER. The reporter plasmids
contain the chloramphenicol acetyltransferase (CAT) gene under the
control of either the grp78 or grp94 promoter and
were kindly provided by A. Lee, University of Southern California
(13, 22). The control CAT reporter plasmid under the control
of the herpes simplex virus type 1 thymidine kinase (tk) promoter was kindly provided by B. M. Peterlin, University of California, San Francisco (28a).
Transient and stable transfections.
For transient-expression
experiments, HuH-7 human hepatoma cells were transfected by the calcium
phosphate method (29). Each 60-mm-diameter plate of cells
was transfected with 5 µg of each plasmid. After 2 days, the cells
were harvested and assayed for CAT activity by thin-layer
chromatography. Triplicate plates were used for each experiment. For
stable expression of E1 or E2 protein, CHO cells were cotransfected
with the appropriate expression plasmid and a plasmid expressing
dihydrofolate reductase, and stable transfectants were selected by
growth in medium containing hypoxanthine-aminopterin-thymidine. Clones
were evaluated for E1 and E2 protein expression by Western blotting,
and one high expresser each was picked for subsequent analysis.
Immunofluorescence, Western blotting, and
immunoprecipitation.
For immunofluorescence, transfected cells
were fixed, permealized with methanol, and exposed first to goat
antibody to GRP78 (1:100 dilution; obtained from Santa Cruz
Biochemicals) and then to fluorescein-labeled rabbit antibody to goat
immunoglobulin G (1:40 dilution; obtained from Sigma). To localize the
transfected cells, E1 or E2 protein was similarly detected by
immunofluorescence (with a 1:200 dilution of murine monoclonal antibody
3D5/C3 to E1 protein or monoclonal antibody 3E5-1 to E2 protein and a
1:50 dilution of rhodamine-labeled rabbit antibody to mouse
immunoglobulin G [obtained from Dako]) (25).
For immunoprecipitation of E2 protein, CHO cells stably expressing E2
protein were lysed with 1% Triton X-100 in phosphate-buffered saline,
pH 7.4. After two rounds of centrifugation at 100,000 × g for 45 min each, the cleared lysates were divided into
equal aliquots and incubated at 4°C with one of two monoclonal
antibodies against E2 protein (3E5-1, which recognizes a linear
epitope, or TE5/H7, which recognizes a conformational epitope), with a monoclonal antibody against GRP78 (SPA827 from StressGen), or with no
antibody. After 1 h, protein A-Sepharose 4B beads (Sigma) were
added, and the mixture was incubated for another hour with gentle
rocking. Following washing four times with 1% Triton X-100 in
phosphate-buffered saline (pH 7.4), the beads were resuspended in
sodium dodecyl sulfate (SDS) sample buffer and boiled for 3 min. The
supernatants were electrophoresed on SDS-10 to 20% polyacrylamide gels and then transferred to a nitrocellulose membrane. The membrane was analyzed by Western blotting with rabbit antibodies to GRP78 (StressGen SPA826), using the alkaline phosphatase (Promega) detection system. Immunoprecipitation of E1 protein was performed similarly with
CHO cells stably expressing E1 protein, except that monoclonal antibody
3D5/C3 to E1 protein was used.
Partial purification of E1 and E2 proteins.
E1 protein was
extracted from stably transfected CHO cells with 1% Triton X-100 in 50 mM Tris-HCl, pH 8.0. The extract was cleared by a 45-min centrifugation
at 10,000 × g and loaded on a Galanthus
nivalis agglutinin (GNA) lectin column. After washing with 1 M
NaCl in buffer A (0.1% Triton X-100 in 20 mM sodium phosphate, pH
6.8), the E1 protein was eluted with 1 M
methyl-
-D-mannopyranoside in buffer A. The E1-containing
eluate was dialyzed against buffer A, and E1 protein was further
concentrated by passing the dialysate through a Sepharose 4B column
(Pharmacia) eluted with 0.5 M NaCl in buffer A. The E1-containing
fraction was analyzed by electrophoresis on SDS-10 to 20%
polyacrylamide gels, followed by Western blotting for GRP78 as detailed
above or for E1 protein with monoclonal antibody 3D5/C3. Purification
of E2 protein was performed in a similar manner with stably transfected
CHO cells. In addition, one aliquot of the crude total extract was
incubated with 10 mM each ATP and MgCl2 (Mg-ATP) for 15 min
before being loaded onto the GNA column.
 |
RESULTS |
To determine the effect of HCV envelope proteins on the
grp78 and grp94 promoters, we used a
transient-transfection assay with HuH-7 human hepatoma cells. One
plasmid expresses the structural proteins of HCV, including core, E1,
E2, and p7, as well as a fragment of the nonstructural protein NS2
(HCV966 in Fig. 1). The other plasmid contains the CAT reporter gene
driven by the grp78 or grp94 promoter. As the
control plasmid for basal CAT expression, pUC19 was used instead of the
expression plasmid. As seen in Fig. 2A,
expression of the HCV structural proteins induced a strong induction of
CAT expression from both the grp78 and grp94
promoters. This cannot be a nonspecific effect of the expression
plasmid we used, since the same vector expressing the HCV NS3 protein
did not have any effect on these promoters (Fig. 2A). Furthermore, the
HCV structural proteins do not have a global effect on gene expression,
since they were not able to activate expression from the herpes simplex
virus tk promoter (Fig. 2A).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Effects of various HCV proteins on CAT expression
driven by the grp78, grp94, or tk promoter in
transient transfection into HuH-7 hepatoma cells. The results are
normalized to CAT expression in the presence of pUC19 and are shown as
the means and standard deviations from three transfections. (B) Effects
of the individual HCV structural proteins on CAT expression driven by
the grp78 or grp94 promoter in transient
transfection into HuH-7 hepatoma cells. The results are normalized to
CAT expression in the presence of pUC19 and are shown as the means and
standard deviations from three transfections.
|
|
To determine which of the HCV structural proteins were affecting the
grp78 and grp94 promoters, we used the same
vector to drive the separate expression of each the individual proteins except p7. As shown in Fig. 2B, neither the core nor the E1 protein had
a significant effect on the grp78 and grp94
promoters. In contrast, the E2 protein was able to induce both
promoters >12-fold (Fig. 2B), while having no effect on the tk
promoter (data not shown). Note that the p7-coding sequences are not
present in this plasmid, thereby ruling out a role for p7. This effect
of E2 is neither cell nor species specific, since it was also able to
activate the grp78 promoter in HT1080 human fibrosarcoma
cells (by 6.0-± 0.9-fold) and in AML12 murine hepatocytes (by 4.6-±
0.2-fold).
Because the E2 protein is expressed to high levels in the transfected
cells, it may be argued that the activation of the grp78 and
grp94 promoters seen here may be simply due to overload of the ER. However, the E1 protein is expressed at similarly high levels
(24a) (Fig. 3), rendering this
possibility unlikely. Furthermore, when a titration of the
E2-expressing plasmid is performed, it is observed that even upon
transfection of small amounts of this plasmid (0.25 µg/60-mm-diameter
dish), there is a substantial activation of the grp94
promoter (Fig. 3). It should be noted that the total amount of
transfected DNA was held constant in these experiments to prevent
fluctuations in the transfection efficiency. Therefore, even relatively
small amounts of E2 protein have the ability to activate transcription.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Titration of the amount of E2-expressing plasmid
cotransfected with the CAT plasmid driven by the grp94
promoter into HuH-7 cells. The total amount of transfected plasmids was
held constant by using pUC19. The results are normalized to CAT
expression in the presence of pUC19 only and are shown as the means and
standard deviations from three transfections.
|
|
In the experiments described above, E2 protein was targeted to the ER
lumen. Therefore, it appears that E2 protein activates transcription
indirectly by influencing an intracellular signaling pathway rather
than acting in the nucleus. Nevertheless, since rare proteins have been
described as being localized to both the ER and the nucleus (1, 6,
19), it was conceivable that a small fraction of the E2 protein
had somehow escaped from the ER to effect a nuclear function. To rule
out this possibility, we deleted the signal sequence from the
E2-expressing plasmid. Indeed, this plasmid did not activate CAT
expression from the grp78 promoter. Instead, for unknown
reasons, it actually decreased expression (0.07 ± 0.01, relative
to pUC19). Possibly the ectopic expression of E2 protein in the cytosol
led to a cytotoxic effect.
Since the CAT reporter plasmid represents an artificial gene expression
system, it was important to determine if E2 protein also affected the
expression of the endogenous cellular grp78 and
grp94 genes. To answer this question, we first transiently transfected the E2-expressing plasmid into HuH-7 cells and used immunofluorescence to estimate the amount of GRP78 protein in these
cells. As exemplified in Fig. 4, top
panels, all cells expressing E2 protein also contained high levels of
GRP78. In contrast, when the same experiment was performed with cells
transfected with the E1-expressing plasmid, the cells that express E1
protein did not show elevated levels of GRP78 (Fig. 4, bottom panels).
Therefore, E2 but not E1 protein is capable of inducing the synthesis
of endogenous cellular GRP78. We were not able to evaluate GRP94 expression in these cells, since nonmurine antibody to GRP94 is not
commercially available. Because immunofluorescence data are not
quantitative, we also used Western blotting to assess the effect of E2
protein on GRP78 and GRP94 expression in a CHO cell line stably
transfected with E2 protein. As seen in Fig.
5, this cell line expresses substantially
more GRP78 and GRP94 than the parental CHO cells, thus confirming the
immunofluorescence data.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 4.
Immunofluorescence detection of GRP78 and E2 or E1
protein expression in HuH-7 cells transiently transfected with either
the E2 (top) or E1 (bottom) expression plasmid. A low level of GRP78 is
detectable in the untransfected cells, as revealed in the original
photographs.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Western blot detection of GRP78 and GRP94 in CHO cells
(lane 1) or CHO cells stably expressing E2 protein (lane 2). Equal
amounts of total cell extracts were separated by SDS-polyacrylamide gel
electrophoresis and transferred to a nitrocellulose membrane for
Western blotting against GRP78. The monoclonal antibody against GRP78
(StressGen SPA826) cross-reacts with GRP94. Numbers on the left are
molecular weights in thousands.
|
|
The immunofluorescence studies (Fig. 4) revealed a substantial overlap
in the distribution of GRP78 and E2 protein in the cell. This
colocalization raised the possibility that these two proteins may be
stably bound to each other. This inference is consistent with the
observation that GRP78 was coimmunoprecipitated from crude cell
extracts when either of two antibodies to E2 protein was used (Fig.
6, lanes 2 and 3) but was not present
when the antibody was omitted (Fig. 6, lane 1). The intensity of the
band was similar to that of the band when anti-GRP78 antibody was used for immunoprecipitation (Fig. 6, lane 4), indicating that the majority
of the GRP78 was associated with E2 protein, since in these experiments
the antibodies were present in excess. Interestingly, antibodies to E1
protein did not precipitate GRP78 from E1-expressing cells (data not
shown), suggesting that E1 protein does not bind strongly to GRP78.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 6.
Coimmunoprecipitation of E2 protein and GRP78. Proteins
were immunoprecipitated from lysates of E2-expressing CHO cells with
either of two different antibodies (Ab) to E2 protein (lanes 2 and 3)
or an antibody to GRP78 ( Grp78) (lane 4), electrophoresed on an
SDS-polyacrylamide gel, and probed for GRP78 by Western blotting. GRP78
was precipitated by all three antibodies; in contrast, no GRP78 was
precipitated when the antibody was omitted (lane 1). Numbers on the
left are molecular weights in thousands.
|
|
Our conclusion that E2 protein stably binds to GRP78 was strengthened
by the observation that a protein migrating at the position expected
for GRP78 copurified with E2 protein after lectin affinity chromatography on GNA (Fig. 7, lane 2).
Indeed, N-terminal sequencing of this protein revealed the sequence
EEEDKK, which corresponds to the known sequence of hamster GRP78
(27). It should be noted that GRP78 is not glycosylated
(15, 24) and thus cannot bind directly to GNA. It is known
that complexes of GRP78 and misfolded proteins are dissociated by
Mg-ATP (18, 28). To determine if this is the case for GRP78
and E2 protein, we added Mg-ATP to lysates of cells expressing E2
protein before purifying the E2 protein on a GNA column. As seen in
Fig. 7, lane 4, GRP78 was indeed absent from E2 protein purified in
this manner. This absence was not due to protein degradation, since
Mg-ATP had no apparent effect on the total proteins present in the
crude lysate (Fig. 7, compare lane 3 to lane 1).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 7.
Copurification of E2 protein and GRP78 in the absence
but not the presence of Mg-ATP. Lysates from E2-expressing CHO cells
were electrophoresed on an SDS-polyacrylamide gel and stained with
Coomassie blue, either before (lanes 1 and 3) or after (lanes 2 and 4)
chromatography on a GNA lectin column. In lanes 3 and 4, the lysate was
preincubated with Mg-ATP for 15 min. Numbers on the left are molecular
weights in thousands.
|
|
In contrast, GRP78 does not appear to be copurified with E1 protein, as
no protein migrating at the expected position was copurified with E1
protein (data not shown). To confirm that GRP78 does not associate with
E1 protein, we performed Western blotting for GRP78 with crude and
partially purified E1 protein. As seen in Fig.
8, there was only a small amount of GRP78
in the crude lysate (lane 3), and this was lost upon enrichment for E1
protein (lane 4; contrast with the large enrichment for E1 protein in lane 2 compared to lane 1). These results confirm that there is a
strong and stable association between GRP78 and E2 protein but not
between GRP78 and E1 protein.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 8.
No evidence for copurification of E1 protein and GRP78.
Lysates from E1-expressing CHO cells were electrophoresed on an
SDS-polyacrylamide gel, transferred to a membrane, and probed for E1
protein (lanes 1 and 2) or GRP78 (lanes 3 and 4) by Western blotting,
either before (lanes 1 and 3) or after (lanes 2 and 4) chromatography
on a GNA lectin column. Numbers in the center are molecular weights in
thousands.
|
|
 |
DISCUSSION |
We have shown that the HCV structural proteins can activate CAT
gene transcription driven by both the grp78 and
grp94 promoters. This property can be ascribed solely to the
E2 envelope protein, which must be targeted to the ER lumen to show
this effect. Furthermore, E2 protein can also increase expression of
the endogenous cellular GRP78. Therefore, E2 protein must activate an
intracellular signaling pathway from the ER to the nucleus to influence
cellular transcription of ER-resident chaperone proteins.
Because the E1 and E2 proteins can form large disulfide-linked
aggregates that accumulate in a pre-Golgi compartment (8, 9), we initially suspected that it is the presence of these presumably misfolded intraluminal proteins that induces
grp78 and grp94 transcription. However, while E2
protein can activate transcription, E1 protein cannot. Yet it has been
shown that E1 protein actually folds much slower than E2 protein and
that its folding is dependent on E2 protein (17). Therefore,
the ability to activate transcription may involve a specific property
of E2 protein and not be simply related to the presence of large
amounts of misfolded proteins in the ER. Thus, even if there is lower expression of E2 protein in the infected hepatocyte, it may be sufficient to increase chaperone protein expression. This inference is
strengthened by our observation that even small amounts of the
cotransfected E2-expressing plasmid have a trans-activation effect.
The mechanism by which E2 protein activates transcription is unknown.
Interestingly, however, our data indicate that E2 protein, unlike E1
protein, is stably bound to GRP78. This binding may explain the
activation of transcription by E2 protein. It has been hypothesized
that GRP78 may itself be a sensor and transducer of ER stress, by
binding to unfolded proteins and then undergoing a conformation change
that eventuates in signal transduction into the nucleus (15,
20). If so, the stable binding of E2 protein to GRP78 would
activate this signaling pathway. During the preparation of this paper,
it was reported that both E1 and E2 proteins bind several intraluminal
chaperones in the ER, including GRP78 (5). However, those
experiments utilized pulse-chase analysis and hence may have detected
transient rather than long-term associations. Furthermore, the amount
of GRP78 bound to E1 protein appeared to be smaller than that bound to
E2 protein (5). Therefore, it is possible that a critical
threshold of the amount and duration of bound GRP78 must be reached
before a signal is sent to the nucleus to increase chaperone expression.
The physiological and pathological significance of this novel effect of
E2 protein is as yet unknown. Interestingly, GRP78 has been shown to
protect cells against killing by cytotoxic T lymphocytes, to increase
the tumorigenicity of transformed cells, and to increase resistance to
antitumor drugs (3, 11, 16, 26). Therefore, it is possible
that by increasing GRP78 expression, E2 protein plays a role in the
chronicity of HCV infection and in HCV-related carcinogenesis. It is
also noteworthy that the hepatitis B virus large surface protein also
activates the grp78 and grp94 promoters
(29). This common feature may explain how these two
disparate viruses cause the identical spectrum of diseases. Further
experiments will be needed to clarify the possible role of E2 protein
in HCV pathogenesis.
 |
ACKNOWLEDGMENTS |
E.L. and Y.-L.F. contributed equally to this work.
We thank Greg Jensen for technical assistance, Jim Ou for critical
reading of the manuscript, Amy Lee and Matija Peterlin for the CAT
plasmids, and Seishi Murakami for helpful discussions.
This work was supported by NIH grant R01CA55578 to T.S.B.Y. E.L. was
partially supported by a UCSF Pathology Department Research Fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Pathology 113B,
4150 Clement St., San Francisco, CA 94121. Phone: (415) 476-6006. Fax: (415) 750-6947. E-mail: yen.ti{at}sanfrancisco.va.gov.
 |
REFERENCES |
| 1.
|
Burns, K.,
B. Duggan,
E. A. Atkinson,
K. S. Famulski,
M. Nemer,
R. C. Bleackley, and M. Michalak.
1994.
Modulation of gene expression by calreticulin binding to the glucocorticoid receptor.
Nature
367:476-480[Medline].
|
| 2.
|
Chapman, B. S.,
R. M. Thayer,
K. A. Vincent, and N. L. Haigwood.
1991.
Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.
Nucleic Acids Res.
19:3979-3986[Abstract/Free Full Text].
|
| 3.
|
Chatterjee, S.,
M. F. Cheng,
S. J. Berger, and N. A. Berger.
1994.
Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide.
Cancer Res.
54:4405-4411[Abstract/Free Full Text].
|
| 4.
|
Choo, Q. L.,
G. Kuo,
A. J. Weiner,
L. R. Overby,
D. W. Bradley, and M. Houghton.
1989.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
Science
244:359-362[Abstract/Free Full Text].
|
| 5.
|
Choukhi, A.,
S. Ung,
C. Wychowski, and J. Dubuisson.
1998.
Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.
J. Virol.
72:3851-3858[Abstract/Free Full Text].
|
| 6.
|
Dedhar, S.,
P. S. Rennie,
M. Shago,
C. Y. Hagesteijn,
H. Yang,
J. Filmus,
R. G. Hawley,
N. Bruchovsky,
H. Cheng,
R. J. Matusik, et al.
1994.
Inhibition of nuclear hormone receptor activity by calreticulin.
Nature
367:480-483[Medline].
|
| 7.
|
Deleersnyder, V.,
A. Pillez,
C. Wychowski,
K. Blight,
J. Xu,
Y. S. Hahn,
C. M. Rice, and J. Dubuisson.
1997.
Formation of native hepatitis C virus glycoprotein complexes.
J. Virol.
71:697-704[Abstract].
|
| 8.
|
Dubuisson, J.,
H. H. Hsu,
R. C. Cheung,
H. B. Greenberg,
D. G. Russell, and C. M. Rice.
1994.
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
J. Virol.
68:6147-6160[Abstract/Free Full Text].
|
| 9.
|
Dubuisson, J., and C. M. Rice.
1996.
Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.
J. Virol.
70:778-786[Abstract].
|
| 10.
|
Houghton, M.
1996.
Hepatitis C viruses, p. 1035-1058.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
|
| 11.
|
Jamora, C.,
G. Dennert, and A. S. Lee.
1996.
Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME.
Proc. Natl. Acad. Sci. USA
93:7690-7694[Abstract/Free Full Text].
|
| 12.
|
Lanford, R. E.,
L. Notvall,
D. Chavez,
R. White,
G. Frenzel,
C. Simonsen, and J. Kim.
1993.
Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells.
Virology
197:225-235[Medline].
|
| 13.
|
Li, W. W.,
S. Alexandre,
X. Cao, and A. S. Lee.
1993.
Transactivation of the grp78 promoter by Ca2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin.
J. Biol. Chem.
268:12003-12009[Abstract/Free Full Text].
|
| 14.
|
Lin, C.,
B. D. Lindenbach,
B. M. Pragai,
D. W. McCourt, and C. M. Rice.
1994.
Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.
J. Virol.
68:5063-5073[Abstract/Free Full Text].
|
| 15.
|
Little, E.,
M. Ramakrishnan,
B. Roy,
G. Gazit, and A. S. Lee.
1994.
The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications.
Crit. Rev. Eukaryot. Gene Expr.
4:1-18[Medline].
|
| 16.
|
Menoret, A.,
K. Meflah, and J. Le Pendu.
1994.
Expression of the 100-kda glucose-regulated protein (GRP100/endoplasmin) is associated with tumorigenicity in a model of rat colon adenocarcinoma.
Int. J. Cancer
56:400-405[Medline].
|
| 17.
|
Michalak, J. P.,
C. Wychowski,
A. Choukhi,
J. C. Meunier,
S. Ung,
C. M. Rice, and J. Dubuisson.
1997.
Characterization of truncated forms of hepatitis C virus glycoproteins.
J. Gen. Virol.
78:2299-2306[Abstract].
|
| 18.
|
Munro, S., and H. R. Pelham.
1986.
An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein.
Cell
46:291-300[Medline].
|
| 19.
|
Ou, J. H.
1997.
Molecular biology of hepatitis B virus e antigen.
J. Gastroenterol. Hepatol.
12:S178-S187[Medline].
|
| 20.
|
Price, B. D.
1992.
Signalling across the endoplasmic reticulum membrane: potential mechanisms.
Cell Signal.
4:465-470[Medline].
|
| 21.
|
Ralston, R.,
K. Thudium,
K. Berger,
C. Kuo,
B. Gervase,
J. Hall,
M. Selby,
G. Kuo,
M. Houghton, and Q. L. Choo.
1993.
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
J. Virol.
67:6753-6761[Abstract/Free Full Text].
|
| 22.
|
Ramakrishnan, M.,
S. Tugizov,
L. Pereira, and A. S. Lee.
1995.
Conformation-defective herpes simplex virus 1 glycoprotein B activates the promoter of the grp94 gene that codes for the 94-kD stress protein in the endoplasmic reticulum.
DNA Cell Biol.
14:373-384[Medline].
|
| 23.
|
Reed, K. E., and C. M. Rice.
1998.
Molecular characterization of hepatitis C virus.
Curr. Stud. Hematol. Blood Transfus.
62:1-37.
|
| 24.
|
Rose, M. D.,
L. M. Misra, and J. P. Vogel.
1989.
KAR2, a karyogamy gene, is the yeast homolog of the mammalian BiP/GRP78 gene.
Cell
57:1211-1221[Medline].
|
| 24a.
| Selby, M. J. Unpublished data.
|
| 25.
|
Selby, M. J.,
Q. L. Choo,
K. Berger,
G. Kuo,
E. Glazer,
M. Eckart,
C. Lee,
D. Chien,
C. Kuo, and M. Houghton.
1993.
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome.
J. Gen. Virol.
74:1103-1113[Abstract/Free Full Text].
|
| 26.
|
Sugawara, S.,
K. Takeda,
A. Lee, and G. Dennert.
1993.
Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity.
Cancer Res.
53:6001-6005[Abstract/Free Full Text].
|
| 27.
|
Ting, J.,
S. K. Wooden,
R. Kriz,
K. Kelleher,
R. J. Kaufman, and A. S. Lee.
1987.
The nucleotide sequence encoding the hamster 78-kDa glucose-regulated protein (GRP78) and its conservation between hamster and rat.
Gene
55:147-152[Medline].
|
| 28.
|
Toledo, H.,
A. Carlino,
V. Vidal,
B. Redfield,
M. Y. Nettleton,
J. P. Kochan,
N. Brot, and H. Weissbach.
1993.
Dissociation of glucose-regulated protein GRP78 and GRP78-IgE Fc complexes by ATP.
Proc. Natl. Acad. Sci. USA
90:2505-2508[Abstract/Free Full Text].
|
| 28a.
|
Tong-Starksen, S. E.,
P. A. Luciw, and B. M. Peterlin.
1987.
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.
Proc. Natl. Acad. Sci. USA
84:6845-6849[Abstract/Free Full Text].
|
| 29.
|
Xu, Z.,
G. Jensen, and T. S. Yen.
1997.
Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum.
J. Virol.
71:7387-7392[Abstract].
|
| 30.
|
Zhou, X. J.,
T. H. Zhang, and J. C. Underwood.
1993.
The ultrastructural pathology of chronic hepatitis C.
Chung-hua Ping Li Hsueh Tsa Chih
22:157-159.
|
Journal of Virology, May 1999, p. 3718-3722, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wati, S., Soo, M.-L., Zilm, P., Li, P., Paton, A. W., Burrell, C. J., Beard, M., Carr, J. M.
(2009). Dengue Virus Infection Induces Upregulation of GRP78, Which Acts To Chaperone Viral Antigen Production. J. Virol.
83: 12871-12880
[Abstract]
[Full Text]
-
Huang, Y., Yang, H., Borg, B. B., Su, X., Rhodes, S. L., Yang, K., Tong, X., Tang, G., Howell, C. D., Rosen, H. R., Thio, C. L., Thomas, D. L., Alter, H. J., Sapp, R. K., Liang, T. J.
(2007). A functional SNP of interferon-{gamma} gene is important for interferon-{alpha}-induced and spontaneous recovery from hepatitis C virus infection. Proc. Natl. Acad. Sci. USA
104: 985-990
[Abstract]
[Full Text]
-
Yu, C.-Y., Hsu, Y.-W., Liao, C.-L., Lin, Y.-L.
(2006). Flavivirus Infection Activates the XBP1 Pathway of the Unfolded Protein Response To Cope with Endoplasmic Reticulum Stress. J. Virol.
80: 11868-11880
[Abstract]
[Full Text]
-
Williams, B. L., Lipkin, W. I.
(2006). Endoplasmic reticulum stress and neurodegeneration in rats neonatally infected with borna disease virus.. J. Virol.
80: 8613-8626
[Abstract]
[Full Text]
-
Chan, C.-P., Siu, K.-L., Chin, K.-T., Yuen, K.-Y., Zheng, B., Jin, D.-Y.
(2006). Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.. J. Virol.
80: 9279-9287
[Abstract]
[Full Text]
-
Isler, J. A., Skalet, A. H., Alwine, J. C.
(2005). Human Cytomegalovirus Infection Activates and Regulates the Unfolded Protein Response. J. Virol.
79: 6890-6899
[Abstract]
[Full Text]
-
Ahmad, A., Alvarez, F.
(2004). Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Biol.
76: 743-759
[Abstract]
[Full Text]
-
Tardif, K. D., Mori, K., Kaufman, R. J., Siddiqui, A.
(2004). Hepatitis C Virus Suppresses the IRE1-XBP1 Pathway of the Unfolded Protein Response. J. Biol. Chem.
279: 17158-17164
[Abstract]
[Full Text]
-
Tardif, K. D., Siddiqui, A.
(2003). Cell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing Cells. J. Virol.
77: 11644-11650
[Abstract]
[Full Text]
-
Pavio, N., Romano, P. R., Graczyk, T. M., Feinstone, S. M., Taylor, D. R.
(2003). Protein Synthesis and Endoplasmic Reticulum Stress Can Be Modulated by the Hepatitis C Virus Envelope Protein E2 through the Eukaryotic Initiation Factor 2{alpha} Kinase PERK. J. Virol.
77: 3578-3585
[Abstract]
[Full Text]
-
Jordan, R., Wang, L., Graczyk, T. M., Block, T. M., Romano, P. R.
(2002). Replication of a Cytopathic Strain of Bovine Viral Diarrhea Virus Activates PERK and Induces Endoplasmic Reticulum Stress-Mediated Apoptosis of MDBK Cells. J. Virol.
76: 9588-9599
[Abstract]
[Full Text]
-
Tardif, K. D., Mori, K., Siddiqui, A.
(2002). Hepatitis C Virus Subgenomic Replicons Induce Endoplasmic Reticulum Stress Activating an Intracellular Signaling Pathway. J. Virol.
76: 7453-7459
[Abstract]
[Full Text]
-
Tsitoura, E., Lucas, M., Revol-Guyot, V., Epstein, A. L., Manservigi, R., Mavromara, P.
(2002). Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. J. Gen. Virol.
83: 561-566
[Abstract]
[Full Text]
-
Op De Beeck, A., Cocquerel, L., Dubuisson, J.
(2001). Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol.
82: 2589-2595
[Full Text]
-
Patel, A. H., Wood, J., Penin, F., Dubuisson, J., McKeating, J. A.
(2000). Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J. Gen. Virol.
81: 2873-2883
[Abstract]
[Full Text]
-
Naganuma, A., Nozaki, A., Tanaka, T., Sugiyama, K., Takagi, H., Mori, M., Shimotohno, K., Kato, N.
(2000). Activation of the Interferon-Inducible 2'-5'-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein. J. Virol.
74: 8744-8750
[Abstract]
[Full Text]
-
Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G. R., Borrow, P., McKeating, J. A.
(2000). Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 Glycoprotein. J. Virol.
74: 702-709
[Abstract]
[Full Text]